{"name":"Jeffrey Gelfand","slug":"jeffrey-gelfand","ticker":"","exchange":"","domain":"","description":"Jeffrey Gelfand is a biotechnology company focused on developing innovative therapies. The company's primary focus has been on FMP30 Donor Stool, which was discontinued. Despite this, the company continues to explore new opportunities in the biotech space.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBiSkVDTEw0UWM0Wjl6MjF6a0RZVGdkWGtWY29IVVZ4Nk5jUEp5anpHWTJ4eWdCMkZCR19lakVoZE9lMno1NVQ0VWdJemtDUktMUFQ1SE0tbG9jbzI0S2hCYTRqQjFrRGp4eEJVZlgySzdpam5KRmc?oc=5","date":"2025-05-09","type":"pipeline","source":"Michigan Today","summary":"‘Science is a team sport’ - Michigan Today","headline":"‘Science is a team sport’","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}